SIRT2 and cardiac hypertrophy: These findings underline the positive role of SIRT2 against pathologic myocardial hypertrophy, indicating SIRT2 as a potential therapeutic intervention target for aging and stress-induced cardiac hypertrophy, which can effectively inhibit the occurrence and development of pathological cardiac hypertrophy.